Health news and commentary gathered by MedPage Today staff
— Health news and commentary gathered by MedPage Today staff
July 22, 2026
• 2 min read
Note that some links may require registration or subscription.
Bottles of the antihistamine cetirizine distributed nationwide by Rising Pharma have been recalled due to potential cross-contamination with ranitidine, according to an FDA notice.
Antihistamine recall across the U.S. triggered by heartburn drug contamination risk, FDA says
Allergy medication recalled after drug mix-up that could be life-threatening, FDA says
Cetirizine hydrochloride: Why was the allergy medication recalled? Check affected lots, risks and what to do
Retiran popular medicamento para la alergia en EE. UU.: la FDA alerta por posible contaminación que podría causar reacciones potencialmente mortales
Pharmalittle: We're reading about Trump's plan for tariffs on generics, a Merck and Gilead HIV pill, and more
Retiran popular antialérgico en EE. UU. por riesgo de contaminación: alerta por posibles reacciones graves
The Potential Havoc Of Generic Drug Tariffs
Patient Advocates Warn Trump Tariffs on Generic Drugs Could Drive Up Costs for Millions | Common Dreams
Rare disease drugmakers try to avoid Trump price cuts
Retiran del mercado comprimidos para la alergia por posible contaminación con otro medicamento
A generic version of the allergy medication Zyrtec is under recall across the U.S. over cross-contamination concerns.
An allergy medication has been recalled for potential cross contamination with Ranitidine.
Rising Pharma Holdings recalled cetirizine hydrochloride tablets. The FDA advises affected consumers to seek medical advice.
Health news and commentary gathered by MedPage Today staff
La Administración de Alimentos y Medicamentos de Estados Unidos (FDA) anunció el retiro de varios lotes de un antihistamínico…
President Trump plans to impose tariffs on imported generic medicines, his latest threat aimed at bringing pharmaceutical…
